ANXA2 and cancer: Conversely, in various cancer cell lines (MCF-7, A549, HT1080, LLC, and 293T) with ANXA2 deficiency, elevated ROS levels, enhanced activation of pro-apoptotic kinases, and increased sensitivity to ROS were also observed [48].